Literature DB >> 11953636

Biologic behavior of an in vitro hydrated collagen gel-human tenocyte tendon model.

Paul M Lamberti1, Frederick H Wezeman.   

Abstract

An in vitro human tenocyte-collagen gel model was developed to study tenocyte-mediated Type I collagen fibril reorganization, proliferation, and Type I collagen gene expression. Human tenocytes, obtained from extrasynovial forearm flexor tendons from children 5 to 10 years of age were cultured on plastic or in a cylinder of hydrated Type I collagen gel. Collagen solution was seeded with human tenocytes at 5 x 10(5) cells/mL and gelled in cylinder molds; gel cylinders without human tenocytes served as controls. Gel cylinders were pinned to troughs to create noncompliance. The gel cylinders were analyzed for collagen birefringence and cell shape at 7 and 21 days and for proliferation and gene expression for Type I collagen at 7 days. Under conditions of noncompliance, human tenocytes reoriented Type I collagen into longitudinal bundles resembling the parallel organization of collagen in native tendons. Tenocyte shape became fusiform between the collagen bundles which mimics the morphologic features of a tenocyte in vivo. The structural changes in the tenocytes and matrix are accompanied by downregulation of human tenocyte proliferation and Type I collagen gene expression. When released from the gel cylinder and grown again on plastic, human tenocytes resume proliferation and Type I collagen gene expression. The human tenocytes in this in vitro gel cylinder model system control fibril reorganization and proliferation, resembling their behavior during the development and repair of native tendons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953636     DOI: 10.1097/00003086-200204000-00049

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Tenocyte proliferation on collagen scaffolds protects against degradation and improves scaffold properties.

Authors:  J M R Tilley; S Chaudhury; O Hakimi; A J Carr; J T Czernuszka
Journal:  J Mater Sci Mater Med       Date:  2011-12-24       Impact factor: 3.896

Review 2.  Tissue engineering for tendon repair.

Authors:  Pierre-Olivier Bagnaninchi; Ying Yang; Alicia J El Haj; Nicola Maffulli
Journal:  Br J Sports Med       Date:  2006-10-24       Impact factor: 13.800

3.  Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells.

Authors:  Dianne Little; Farshid Guilak; David S Ruch
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

4.  Cytotoxicity of tranexamic acid to tendon and bone in vitro: Is there a safe dosage?

Authors:  Scott M Bolam; Arama O'Regan-Brown; Subhajit Konar; Karen E Callon; Brendan Coleman; Nicola Dalbeth; A Paul Monk; David S Musson; Jillian Cornish; Jacob T Munro
Journal:  J Orthop Surg Res       Date:  2022-05-15       Impact factor: 2.677

5.  Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes.

Authors:  Ann K Rosenthal; Claudia M Gohr; Elizabeth Mitton; Vincent Monnier; Todd Burner
Journal:  J Investig Med       Date:  2009-02       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.